Smith Nicholas Conrad bought ANRO

October 2, 2026 · Form 4 insider transaction

Smith Nicholas Conrad bought 55,000 shares of Alto Neuroscience, Inc. at $2.32 per share, a transaction worth $127.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.